Prevention of hemoglobinopathies in Egypt

Hemoglobin

Volumn 33, Issue SUPPL. 1, 2009, Pages

  El Beshlawy, Amal ^a   Youssry, Ilham ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Hemoglobinopathies; Premarital screening; Prenatal diagnosis; Prevention program; Sickle cell disease; Thalassemia

Indexed keywords

PENICILLIN G; TRANSFERRIN;

BETA THALASSEMIA; COLUMN CHROMATOGRAPHY; CONFERENCE PAPER; DOPPLER ECHOGRAPHY; EGYPT; HUMAN; MEAN CORPUSCULAR VOLUME; NEWBORN SCREENING; OSMOTIC FRAGILITY; SICKLE CELL ANEMIA; STROKE;

ANEMIA, SICKLE CELL; EGYPT; GENETIC COUNSELING; GENETIC TESTING; HEMOGLOBINOPATHIES; HETEROZYGOTE DETECTION; HUMANS; PREMARITAL EXAMINATIONS; PRENATAL DIAGNOSIS; THALASSEMIA;

EID: 73949104323     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903346395     Document Type: Conference Paper

References (18)

1. El-Beshlawy A, Kaddah N, Mostaza A, Mouktar G, Youssry I. Screening for b-thalassemia carriers in Egypt: Significance of the osmotic fragility test. East Mediterr Health J. 2007;13(4):780-786.
2. Weatherall DJ. Hemoglobinopathies worldwide: Present and future. Curr Mol Med. 2008;8(7): 592-599.
3. Morris CR, Singer ST, Walters MC. Clinical hemoglobinopathies: Iron, lungs and new blood. Curr Opin Hematol. 2006;13(6):407-418.
4. Ibrahim N, Kamel K, Selim O. Heriditary blood factors and anthropology of inhabitants of the Egyptian Siwa Oasis. Hum Biol. 1974;46(1):57-68.
5. Meremikwu M. Sickle cell disease. Clin Evid. 2006;(15):45-59.
6. Cao A, Rosatelli MC, Galanello R. Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: The Sardinian experience. Ciba Found Symp. 1996;197:137-151.
7. Hafez M, El-Tahan H, Awadalla M, El-Khayat H, Abdel-Gafar A, Ghoneim M. Consanguineous matings in the Egyptian population. J Med Genet. 1983;20(1):58-60.
8. Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet. 1981;1(8216):369-371.
9. Colah R, Surve R, Wadia M, et al. Carrier screening for beta-thalassemia during pregnancy in India: A 7-year evaluation. Genet Test. 2008;12(2):181-185.
10. Sanchaisuriya K, Fucharoen S, Fucharoen G, et al. A reliable screening protocol for thalassemia and hemoglobinopathies inpregnancy: An alternative approach to electronic blood cell counting. Am J Clin Pathol. 2005;123(1):113-118.
11. Wiwanitkit V, Suwansaksri J, Paritpokee N. Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol(DCIP) test screening for hemoglobin disorders, an experience in 213 Thai Pregnant women. Clin Lab. 2002;48(9-10):525-528.
12. El-Tayeb EN, Yaqoob M, Abdur-Rahim K, Gustavson KH. Prevalence of beta-thalassaemia and sickle cell traits in premarital screening in Al-Qassim, Saudi Arabia. Genet Couns. 2008;19(2):211-218.
13. Elgawhary S, Elbaradie Sahar MY, Rashad WM, et al. Prenatal diagnosis of beta-thalassemia in Egypt: Implementing accurate high-tech methods did not reflect much on the outcome. Pediatr Hematol Oncol. 2008;25(6):541-548.
14. Theodoridou S, Alemayehou M, Prappas N, et al. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years. Hemoglobin. 2008;32(5):434-439.
15. Nikuei P, Hadavi V, Rajaei M, Saberi M, Hajizade F, Najmabadi H. Prenatal diagnosis for betathalassemia major in the Iranian Province of Hormozgan. Hemoglobin. 2008;32(6):539-545.
16. Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: A critical review of the literature and transfusion guidelines. Transfus Med Rev. 2007;21(2):118-133.
17. Gaston MH, Verter JI, Woods G. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med. 1986;314:1593-1599.
18. Qureshi N, Lubin B, Walters MC. The prevention and management of stroke in sickle cell anaemia. Expert Opin Biol Ther. 2006;6(11):1087-1098.